Furthermore, high expression of CXCL10 was related to a poor prognosis, suggesting that CRC‐derived exosomal CXCL10 may be a novel biomarker for patients with CRLM, but more work is needed to verify its suitability as a biomarker for liver metastasis.128. This evidence concerns the gene CXCL10 and colorectal carcinoma.